Syeda Seirut Javed
Tue, February 10, 2026 astatine 8:54 AM CST 1 min read
Tempus AI, Inc. (NASDAQ:TEM) is 1 of the stocks Jim Cramer looked astatine recently. When a caller asked if the banal is simply a buy, sell, oregon hold, Cramer said:
Well, you cognize we’re not recommending stocks that are losing a batch of wealth present conscionable due to the fact that the twelvemonth of magical investing made a return, and I deliberation that you got a small reprieve, and it’s going to spell backmost down again.
Tempus AI, Inc. (NASDAQ:TEM) develops exertion that organizes and analyzes ample amounts of objective and molecular information to assistance doctors personalize diligent care. The company’s level uses AI to tally diagnostic tests, lucifer patients with objective trials, and assistance pharmaceutical companies successful discovering caller crab treatments successful strategical partnerships with companies similar AstraZeneca and Pathos AI. A caller asked astir the banal during the July 9, 2025, occurrence and Cramer replied:
Okay, different institution that’s conscionable losing wealth manus implicit fist. I conscionable can’t spell there. You know, erstwhile it comes to AI, you cognize what I judge in? I judge successful NVIDIA.
It is worthy noting that the company’s banal is down astir 6% from the time the supra remark was aired.
While we admit the imaginable of TEM arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.
READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.

1 month ago
11





English (CA) ·
English (US) ·
Spanish (MX) ·